HK99593A - Pharmaceutical compositions containing a dideoxynucleoside - Google Patents

Pharmaceutical compositions containing a dideoxynucleoside Download PDF

Info

Publication number
HK99593A
HK99593A HK995/93A HK99593A HK99593A HK 99593 A HK99593 A HK 99593A HK 995/93 A HK995/93 A HK 995/93A HK 99593 A HK99593 A HK 99593A HK 99593 A HK99593 A HK 99593A
Authority
HK
Hong Kong
Prior art keywords
dideoxycytidine
tablet
dideoxynucleoside
ingredients
formulations
Prior art date
Application number
HK995/93A
Other languages
English (en)
French (fr)
Inventor
Whaijen Soo
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of HK99593A publication Critical patent/HK99593A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (1)

  1. Die Verwendung von 2',3'-Dideoxycytidin bei der Herstellung eines Medikaments zur Bereitstellung einer Dosierungseinheit mit einer für die Verabreichung von 0.001 bis 0,05 mg/kg/Tag an einen Patienten zwecks Verhütung oder Behandlung von AIDS hinreichenden Menge 2',3'-Dideoxycytidin.
HK995/93A 1987-09-18 1993-09-23 Pharmaceutical compositions containing a dideoxynucleoside HK99593A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9825587A 1987-09-18 1987-09-18

Publications (1)

Publication Number Publication Date
HK99593A true HK99593A (en) 1993-09-30

Family

ID=22268410

Family Applications (1)

Application Number Title Priority Date Filing Date
HK995/93A HK99593A (en) 1987-09-18 1993-09-23 Pharmaceutical compositions containing a dideoxynucleoside

Country Status (13)

Country Link
EP (1) EP0307914B1 (de)
JP (1) JP2648329B2 (de)
KR (1) KR960014991B1 (de)
AT (1) ATE78693T1 (de)
AU (1) AU616427B2 (de)
CA (1) CA1334166C (de)
DE (1) DE3873232T2 (de)
HK (1) HK99593A (de)
HU (1) HUT47856A (de)
IE (1) IE62191B1 (de)
IL (1) IL87776A (de)
PH (1) PH24796A (de)
ZA (1) ZA886107B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
EP0355245A1 (de) * 1988-08-26 1990-02-28 Michel Vandevelde Anwendung von Inhibitoren der reversen Transcriptase von Retroviren
CA2054771A1 (en) * 1989-05-15 1990-11-16 Hiroaki Mitsuya Method of treatment of hepatitis
EP0472595A4 (en) * 1989-05-15 1992-07-08 Us Commerce Method of treatment of hepatitis
ES2060373T3 (es) * 1990-04-19 1994-11-16 Previsan Sa Derivados azoicos, compuestos farmaceuticos y desinfectantes que los contienen y su utilizacion contra el sida.
US5585367A (en) * 1990-04-19 1996-12-17 Previsan S.A. Method of treating humans and animals infected with viruses of the retrovirus group
JP2593409Y2 (ja) * 1992-12-02 1999-04-12 エスエムケイ株式会社 キーボードスイッチ
DE4419256A1 (de) * 1994-06-01 1995-12-07 Rau Freiherr Von Nagell Helmut Verwendung von intravenös applizierbarem Eisen zur Therapie von Tumorerkrankungen und/oder Infektionskrankheiten
DE4421159C1 (de) * 1994-06-20 1995-08-24 Thomas Bruns Verwendung von Eisen(III)-oxid (Fe¶2¶O¶3¶) bei Immunschwäche

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8801303A1 (es) * 1985-05-15 1987-12-16 Wellcome Found Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
GB8512542D0 (en) * 1985-05-17 1985-06-19 Atomic Energy Authority Uk Improved cutting edges
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
WO1987001283A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxycytidine

Also Published As

Publication number Publication date
IE882836L (en) 1989-03-18
DE3873232D1 (de) 1992-09-03
KR890004705A (ko) 1989-05-09
PH24796A (en) 1990-10-30
JPS6483020A (en) 1989-03-28
IE62191B1 (en) 1994-12-28
EP0307914A2 (de) 1989-03-22
AU2234588A (en) 1989-03-23
JP2648329B2 (ja) 1997-08-27
EP0307914A3 (en) 1989-08-09
DE3873232T2 (de) 1992-12-03
CA1334166C (en) 1995-01-31
HUT47856A (en) 1989-04-28
EP0307914B1 (de) 1992-07-29
IL87776A (en) 1994-01-25
ZA886107B (en) 1989-04-26
KR960014991B1 (ko) 1996-10-23
ATE78693T1 (de) 1992-08-15
AU616427B2 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
US4879277A (en) Antiviral compositions and methods
JPH0215523B2 (de)
EP0307914B1 (de) Ein Dideoxynukleosid enthaltendes Arzneimittel
Whitley Therapeutic approaches to varicella-zoster virus infections
US4438138A (en) Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
EP0629400B1 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
US5028595A (en) Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
Jacobson et al. Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet
WO2023128427A1 (ko) 폴리감마글루탐산을 유효성분으로 포함하는 코로나바이러스(sars-cov-2) 감염질환의 예방, 경감 또는 치료용 약학적 조성물
KR0143410B1 (ko) B형 비루스성 간염치료용 제약학적 조성물
CA2238770A1 (en) Use of a combination of pentoxifylline and type i interferons for treating multiple sclerosis
US4666889A (en) Method for combatting viral infections
JPS63267781A (ja) 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
US5955498A (en) Agent for prophylaxis and therapy of diseases
US4303658A (en) Antiviral pyrazolopyrazines
JP2007297412A (ja) ヒト・ヘルペスウイルス−８の治療に対するペンシクロビルの使用
EP0338404A1 (de) Verwendung von Megestrol-Acetat zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Aids-verbundener Kachexie
EP0245954B1 (de) Verwendung von Etodolac zur Senkung des Blutgehalts an Harnsäure
US4971977A (en) Anti-viral pharmaceutical compositions
US4230725A (en) Antiviral agent
US4537908A (en) Herpes II treatment
JPH05170646A (ja) 抗エイズウイルス剤
Collignon et al. Neurological toxicity associated with vidarabine (adenine arabinoside) therapy
JPH06199674A (ja) 日和見感染症の治療・予防に関する医薬
EP0488041A2 (de) Pharmazeutische Zusammensetzung gegen Cytomegalovirusinfektion

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080914